Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2022-04-26 Major Shareholding Noti…
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement from the London Stock Exchange, indicated by the 'RNS Number' and the footer mentioning the FCA. The content is a 'TR-1: Standard form for notification of major holdings' concerning UBS Investment Bank's holdings in Oncimmune Holdings PLC falling below the 5% threshold. This type of filing, which reports changes in significant share ownership, directly corresponds to the 'Major Shareholding Notification' definition. Therefore, the filing type code is MRQ.
2022-04-26 English
Queen’s Award for Enterprise in Innovation 2022
Environmental & Social Information Classification · 99% confidence The document begins with 'RNS Number : 8079I' and is distributed via 'RNS Reach'. It announces a specific, non-financial corporate event: Oncimmune receiving the Queen's Award for Enterprise 2022 in the innovation category. This is a general corporate announcement that does not fit into specific financial reporting categories like 10-K, ER, or IR. Since it is a formal announcement distributed through the RNS system, and it is not a standard regulatory filing (it is explicitly labeled as 'Reach' and 'non-regulatory'), the most appropriate classification is the general regulatory/news announcement category, RNS, as it serves as a broad communication channel for such news.
2022-04-21 English
Exercise of Options, PDMR Dealing and TVR
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement released via RNS (RNS Number: 4441I) on April 14, 2022. The content explicitly details transactions conducted by a Person Discharging Managerial Responsibilities (PDMR), specifically the Chief Financial Officer, involving the exercise of options and subsequent sale of Ordinary Shares. This type of insider transaction disclosure, especially when referencing FCA Disclosure Guidance and Transparency Rules and detailing director dealings, directly corresponds to the 'Director's Dealing' category. The presence of the RNS header and the specific nature of the disclosure confirm this is not a general regulatory filing (RNS) or a report publication announcement (RPA), but a specific disclosure type.
2022-04-14 English
Two further ImmunoINSIGHTS contracts signed
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated '08 April 2022'. It announces the signing of two new commercial contracts ('Two further ImmunoINSIGHTS contracts signed'). The text concludes with standard boilerplate information from RNS, stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief announcement of a material event disseminated via the RNS system—is characteristic of a general regulatory announcement that doesn't fit a more specific category like 10-K, ER, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (7222 chars) is substantial enough to be more than just a placeholder, but its primary function is regulatory dissemination.
2022-04-08 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed with the RNS (Regulatory News Service) of the London Stock Exchange. This form is used to report changes in significant share ownership (crossing thresholds). This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a major holding disclosure, making MRQ the most precise classification over the general RNS fallback.
2022-04-04 English
Exercise of Options, PDMR Dealing and TVR
Director's Dealing Classification · 99% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement from the London Stock Exchange, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the FCA. The content details the 'Exercise of Options, PDMR Dealing and Total Voting Rights' by the Chief Financial Officer, Matthew Hall. This type of mandatory disclosure regarding insider transactions (Director's Dealing) and changes in total voting rights, when released via the RNS system, is best classified based on the distribution mechanism and the nature of the disclosure. Since the primary purpose is a regulatory notification about insider transactions (Director's Dealing), the most specific code is DIRS. However, the document is distributed via RNS, which is a general regulatory announcement channel. Given the options, 'DIRS' (Director's Dealing) is the most specific content classification for the core subject matter (PDMR dealing), while 'RNS' is the distribution channel. Since the definitions prioritize content (e.g., DIRS for director transactions), DIRS is the primary fit. If the document were purely an announcement *about* an RNS release without the details, RPA or RNS would be better. Since it contains the full details of the dealing, DIRS is appropriate. The presence of 'RNS Number' and the LSE boilerplate strongly suggests it is a regulatory filing, but DIRS is more precise than the general RNS fallback.
2022-03-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.